DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Zantac (Ranitidine) - Adverse Event Reports - Disability - Blood Creatine Phosphokinase Increased

 



Index of reports > Cases resulting in disability (2) > Cases with Blood Creatine Phosphokinase Increased (1)

Below is the selection of adverse event reports related to Zantac (Ranitidine) that includes cases resulting in disability where reactions include blood creatine phosphokinase increased.

Adverse event in 87 year old female receiving Zantac (Ranitidine)

Reported by a physician from Japan on 2007-03-29

Patient: 87 year old female, weighing 38.0 kg (83.6 pounds)

Adverse reactions / side effects: Blood Creatine Phosphokinase Increased, Rhabdomyolysis, Delirium, Anorexia, Depressed Level of Consciousness, Renal Failure Acute, Shock, White Blood Cell Count Increased

Adverse event resulted in: life threatening event, hospitalization, disablity

Suspect drug(s):
Allopurinol
    Dosage: 100mg per day
    Administration route: Oral
    Start date: 2007-02-08

Zantac
    Dosage: 150mg per day
    Administration route: Oral
    Start date: 2007-02-08

Other drugs received by patient: Renivace; Artist; Amlodin; Unknown Medication

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009